What is Neumora Therapeutics, Inc. Common Stock's Market Cap?

Neumora Therapeutics, Inc. Common Stock's Market Cap is $238.6M, based on as-reported figures from SEC (XBRL) filings.

What is Neumora Therapeutics, Inc. Common Stock's Enterprise Value?

Neumora Therapeutics, Inc. Common Stock's Enterprise Value is $234.7M, based on as-reported figures from SEC (XBRL) filings.

What is Neumora Therapeutics, Inc. Common Stock's EV / EBITDA?

Neumora Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Neumora Therapeutics, Inc. Common Stock's Net Income (TTM)?

Neumora Therapeutics, Inc. Common Stock's Net Income (TTM) is -$212.7M, based on as-reported figures from SEC (XBRL) filings.

What is Neumora Therapeutics, Inc. Common Stock's EBITDA?

Neumora Therapeutics, Inc. Common Stock's EBITDA is -$211.2M, based on as-reported figures from SEC (XBRL) filings.

What is Neumora Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Neumora Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.13, based on as-reported figures from SEC (XBRL) filings.

What is Neumora Therapeutics, Inc. Common Stock's Net Debt?

Neumora Therapeutics, Inc. Common Stock's Net Debt is -$3.9M, based on as-reported figures from SEC (XBRL) filings.

Neumora Therapeutics, Inc. Common Stock (NMRA) Financial Statements

Neumora Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG012W9C504

XNAS · usd

1.27▲ 0.02 (1.60%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.25

Day's Range1.24 – 1.34

52-Week Range0.83 – 3.66

Volume755.3K

Avg Volume702.0K

Share Statistics

Shares Outstanding

Employees96

ExchangeXNAS

Listed2023-09-15

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Neumora Therapeutics, Inc. Common Stock (NMRA)

What is Neumora Therapeutics, Inc. Common Stock's Market Cap?: Neumora Therapeutics, Inc. Common Stock's Market Cap is $238.6M, based on as-reported figures from SEC (XBRL) filings.
What is Neumora Therapeutics, Inc. Common Stock's Enterprise Value?: Neumora Therapeutics, Inc. Common Stock's Enterprise Value is $234.7M, based on as-reported figures from SEC (XBRL) filings.
What is Neumora Therapeutics, Inc. Common Stock's EV / EBITDA?: Neumora Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Neumora Therapeutics, Inc. Common Stock's Net Income (TTM)?: Neumora Therapeutics, Inc. Common Stock's Net Income (TTM) is -$212.7M, based on as-reported figures from SEC (XBRL) filings.
What is Neumora Therapeutics, Inc. Common Stock's EBITDA?: Neumora Therapeutics, Inc. Common Stock's EBITDA is -$211.2M, based on as-reported figures from SEC (XBRL) filings.
What is Neumora Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Neumora Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.13, based on as-reported figures from SEC (XBRL) filings.
What is Neumora Therapeutics, Inc. Common Stock's Net Debt?: Neumora Therapeutics, Inc. Common Stock's Net Debt is -$3.9M, based on as-reported figures from SEC (XBRL) filings.